Nopalea Daily Cleanse
Natural health product licensed in Canada
- Licence holder
- TriVita Living Ltd.
- NPN or DIN-HM
- 80047461
- Status
- Inactive licence
- Licence date
- 9 January 2014
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Citrus bergamia Source : Fruit | 10 mg | Not calculated |
| Silybum marianum Source : Graine(s) Potency : 80 % Silymarin | 50 mg | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 40 mg | 10 mg | Not calculated |
| Salvia officinalis Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
| Curcuma longa Source : Rhizome Potency : 5 % Curcumin | 50 mg | Not calculated |
| Taraxacum officinale Source : Plante entière Extraction ratio : 4:1 Dry plant equivalent : 40 mg | 10 mg | Not calculated |
Non-medicinal ingredients
Jus d'Aloès, Gomme de xanthane, Saveur d'orange, Oxyde de magnésium, Saveur de banane, Jus de canne à sucre, Saveur de fraise, Concentré de jus de betterave, Feuille de Stevia rebaudiana, Acide citrique, Acide DL-malique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 packet | 1 day |
Uses authorised in Canada
Laxative. Source of fiber for the maintenance of good health. Provides antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defaecate following the use of another laxative product. Do not use if you have diabetes mellitus in which blood sugar is difficult to regulate. If you are pregnant or breastfeeding, do not use this product. If you have a seizure (e.g. epilepsy), do not use this product. Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Do not use if you have a bile duct obstruction. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking other products containing diuretics, corticosteroids or licorice, do not use. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you have a history of kidney stones. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms, and / or diarrhea. Consult a heath care practitioner if symptoms worsen or if laxative effect does not occur within seven days. Consult a health care practitioner immediately if you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product. Consult a health care practitioner prior to use if you are taking medications which inhibit peristaltic movement (e.g. opioids, loperamide). Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and / or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis). Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid.
- Effets indésirables connus
Hypersensitivity, such as allergy has been known to occur following inhaled and / or indigested psyllium; in which case, discontinue use. May cause temporary gas and / or bloating.
Source
Official Health Canada record, licence 80047461
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.